Statin Use in the U.S. for Secondary Prevention of Cardiovascular Disease Remains Suboptimal

Journal of the American Board of Family Medicine: JABFM

article

Quyen Ngo-Metzger¹  Samuel Zuvekas²  Paul Shafer²  Howard Tracer²  Amanda E. Borsky²  Arlene S. Bierman² 

[1] Kaiser Permanente School of Medicine;From the Agency for Healthcare Research and Quality;Department of Health Law, and Management, School of Public Health, Boston University

关键词: Atherosclerosis;    Cardiovascular Diseases;    Chronic Disease;    Hypercholesterolemia;    Hyperlipidemia;    Logistic Models;    Preventive Medicine;    Secondary Prevention;    Statins;    Surveys and Questionnaires;   

DOI  :  10.3122/jabfm.2019.06.180313

学科分类：过敏症与临床免疫学

来源: The American Board of Family Medicine

【 摘 要 】

Background: Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of mortality in the United States. The purpose of this study is to examine the rates of statin use for secondary prevention of ASCVD events in the United States over the last decade and determine whether disparities in the treatment of ASCVD still persist among women and racial/ethnic minorities.

【 授权许可】

CC BY